Western blotting, qRT-PCR, and luciferase reporter assays using cancer cell lines (HeLa and A549) revealed that TH3 is able to repress the transcription of c-MYC at a protein level without affecting BCL2 expression, suggesting the preferential recognition and stabilization of the c-MYC G4 by TH3. Here, BCL2 is linked to cancer.